Evidence map›Paper›PMID 34769411›Full record

ArticleInternational journal of molecular sciences2021

Improvement of an Effective Protocol for Directed Differentiation of Human Adipose Tissue-Derived Adult Mesenchymal Stem Cells to Corneal Endothelial Cells.

Cadenas-Martin Marta, Moratilla Adrian, Fernández-Delgado Jorge, Arnalich-Montiel Francisco, Maria P De Miguel

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Biomedical Application of MSCs in Corneal Regeneration and Repair.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Article
  6. Focus on seed cells: stem cells in 3D bioprinting of corneal grafts.Frontiers in bioengineering and biotechnology · 2024
    Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Cadenas-Martin MartaCell Engineering Laboratory, La Paz University Hospital Health Research Institute, IDiPAZ, 28046 Madrid, Spain.
Moratilla AdrianCell Engineering Laboratory, La Paz University Hospital Health Research Institute, IDiPAZ, 28046 Madrid, Spain.
Fernández-Delgado JorgeDepartment of Plastic and Reconstructive Surgery, Santa Cristina Hospital and Centrocim, 28009 Madrid, Spain.
Arnalich-Montiel FranciscoOphthalmology Department, Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria, 28034 Madrid, Spain.
Maria P De MiguelCell Engineering Laboratory, La Paz University Hospital Health Research Institute, IDiPAZ, 28046 Madrid, Spain.
Hospital La Paz Institute for Health Research · ESHospital Universitario Santa Cristina · ESInstituto Ramón y Cajal de Investigación Sanitaria · ES

Funding

Domingo Martinez Foundation 0016Foundation Jesús Antolín Garciarena FIBHULP06Roche Farma FIBHULP3Stem Vision 01
6 · The paper itself

Abstract

Corneal disease affects 12.5 million individuals worldwide, with 2 million new cases each year. The standard treatment consists of a corneal transplantation from a human donor; however, the worldwide demand significantly exceeds the available supply. Lamellar endothelial keratoplasty, the replacement of only the endothelial layer of the cornea, can partially solve the problem. Progressive efforts have succeeded in expanding hCECs; however, the ability to expand hCECs is still limited, and new sources of CECs are being sought. Crucial advances have been achieved by the directed differentiation of embryonic or induced pluripotent stem cells, but these cells have disadvantages, such as the use of oncogenes, and are still difficult to establish. We aimed to transfer such knowledge to obtain hCECs from adipose tissue-derived adult mesenchymal stem cells (ADSC) by modifying four previously published procedures. We present several protocols capable of the directed differentiation of human ADSCs to hCECs. In our hands, the protocol by Ali et al. was the best adapted to such differentiation in terms of efficiency, time, and financial cost; however, the protocol by Wagoner et al. was the best for CEC marker expression. Our results broaden the type of cells of autologous extraocular origin that could be employed in the clinical setting for corneal endothelial deficiency.

Indexed as

AdultCell Culture TechniquesCell DifferentiationCells, CulturedCorneal DiseasesCorneal TransplantationEndothelium, CornealFemaleHumansMesenchymal Stem CellsMiddle AgedTissue DonorsTissue Engineeringadipose tissue-derived mesenchymal stem cellscell reprogrammingcorneacorneal endotheliumdifferentiation

Identifiers

PMID34769411
PMCPMC8585097
OpenAlexW3212651991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.